Business · 28/12/2020
FDA Renewal of Cellular, Tissue and Gene Therapies Advisory Committee
The Food and Drug Administration (FDA) is renewing the Cellular, Tissue and Gene Therapies Advisory Committee for an additional 2 years, with the new charter set to expire on October 28, 2024, at the request of the Commissioner of Food and Drugs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →